Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the
past decades, and are now the most common type of small bowel tumor. Consequently …

The small intestine and pancreas are among the most frequent abdominal sites of origin of
neuroendocrine tumours. Distinctive features of these forms are represented by the relatively …

Small bowel neuroendocrine tumors (SB-NETs) are increasingly identified and have
become the most frequent entity among small bowel tumors. An increasing incidence, a high …

This guideline was created for the first time and is intended as a practical aid for the
diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of …

Objective: The aim of the study was to compare impact on survival after resection of primary
tumors (PTs) after peptide receptor radionuclide therapy (PRRT). Background: PRRT is a …

Small-intestinal neuroendocrine tumors (SI-NETs) are the most prevalent small bowel
neoplasms with an increasing frequency. In the multimodal management of SI-NETs …

The widespread use of endoscopy and imaging in combination with the continuous update
of the staging systems for neuroendocrine tumors has led to an increase in the incidence of …

Strong evidence comparing different treatment options for liver metastases (LM) arising from
gastroenteropancreatic neuroendocrine tumours (GEP-NET) is lacking. The aim of this study …

Simple Summary Small-intestinal neuroendocrine tumors (siNETs) account for 25% of
gastroenteropancreatic NETs. A total of 89% of multiple tumors are located in the ileum …

Background Small bowel neuroendocrine tumors (SB‐NETs) are often small, multifocal,
difficult to localize preoperatively, and can be overlooked during operative exploration. The …